Becker's Healthcare September 23, 2024
Amid expectations that the popularity of GLP-1 drugs will decrease bariatric surgery rates, a Cleveland Clinic-led study found these surgeries might be more effective than GLP-1s for some patients.
Cleveland Clinic researchers analyzed chronic kidney disease progression and incident kidney failure data among 425 patients who either underwent metabolic surgery or continuously took GLP-1s for at least two years. All had Type 2 diabetes, obesity and stage 3 or 4 chronic kidney disease.
Compared to GLP-1s, metabolic surgery was associated with a 60% lower risk of kidney disease progression and a 44% lower risk...
Today's Sponsors
Today's Sponsor